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New Positive, Tetrazol ium-Linked,  Staining Method for Use with Electrophoresis of Phosphoglycerate 
Kinase 
Phosphog lyce ra te  kinase (PGK;  EC 2.7.2.3) has.  been  
the  subjec t  of considerable  recent  interest .  I t  has  been 
shown to be a sex- l inked enzyme  in the  h u m a n  popula-  
t ion 1,2 and, as such, promises  to be a useful tool  in s tudies  
involving X- l inked  genes. This  enzyme  has an i m p o r t a n t  
funct ional  role in me tabo l i sm  as one of the  adenosine  
t r i phospha te  (ATP)-genera t ing  enzymes  of glycolysis. In  
humans ,  a def ic iency of th is  enzyme  leads to a t ype  of 
congeni ta l  nonspherocy t i c  anemia  1,8. Ano the r  factor  
adding  to the  impor t ance  of th is  enzyme  is tha t ,  in red 
blood cells, it  can be  bypassed  b y  a two-enzyme  s h u n t  
which produces  2 ,3-diphosphoglycera te  (2, 3-DPG). This 
in t e rmed ia te  has been  ex tens ive ly  s tudied  because of its 
role in modi fy ing  the  oxygen aff in i ty  vurve  of hemoglo-  
bin 4. Thus,  the  re la t ive act ivi t ies  of P G K  and the  2, 3-DPG 
shun t  enzymes  become i m p o r t a n t  in de te rmin ing  red cell 
levels of 2,3 -DPG and  ATP.  Figure  1 i l lus t ra tes  the  gly- 
colytic role of P G K  and  i ts  re la t ion to the  2 ,3 -DPG 
shunt .  
P rev ious  e lec t rophore t ic  s tudies  of P G K  have  been  
concerned wi th  h u m a n  red cell P G K  and  have  used 
absence of f luorescence as an indica t ing  sys t em ~,~. This  
communica t ion  describes a new s ta in ing t echn ique  for 
P G K  ac t iv i ty  uti l izing a posi t ive  s ta in  l inked to a t e t ra -  
zolium dye. 
Methods. The basic s t ra tegy  for our P G K  st ra in  is 
similar to t h a t  descr ibed by  BREWER 6 for p y r u v a t e  kinase 
and creat ine kinase, t h a t  is, the  A T P  formed by  the  
P G K  react ion is de tec ted  by  a hexokinase  (HK)/glucose-  
6-phosphate  dehydrogenase  (G6PD)/3-(4, 5 Dimethy l th i a -  
zolyl-2)-2,5 d ipheny l  te t razo l ium (MTT) sys tem.  Phos-  
phoglycera te  kinase is de tec ted  in s ta rch  gels by  means  of 
an agar  over lay  conta in ing  1, 3-d iphosphoglycera te  (1, 3- 
DPG} and  adenosine  d iphospha t e  (ADP}. The  P G K  
produces  ATP,  which,  in turn,  acts  on the  H K / G 6 P D /  
MTT sys tem and leads to colored bands  of reduced MTT. 
The presen t  commerc ia l  unava i lab i l i ty  of 1 ,3-DPG 
necess i ta tes  a genera t ing  sys t em for this  subs t ra te .  The  
1, 3-DPG is genera ted  in v i t ro  by  the  glyceraldehyde-3-  
phospha t e  dehydrogenase  (GAPD) enzymat ic  react ion 
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Fig. 1. Reactions relating phosphoglyeerate kinase to its stain, the 
2,3-diphosphoglyeerate shunt, and adenylate kinase. The 1,3-DPG 
generating system is blocked off in the above figure. Abbreviations: 
GAP, glyceraldehyde-3-phosphate; Pi, inorganic phosphate; GAPD, 
glyeeraldehyde-3-phosphate dehydrogenase; NAD and NADH, oxi- 
dized and reduced nietotinamide adenine dinueleotide, respectively-; 
LDH, lactate dehydrogenase; 1,3-DPG, 1,3-diphosphoglyeerate; 
DPGM, diphosphoglycerate mutase; 2, 3-DPG, 2, 3-diphoshoglycerate; 
DPGP, 2, 3-diphosphoglycerate phosphatase; ADP, adenosine diphos- 
phate; PGK, phosphogiycerate kinase; 3-PG, 3-phosphoglycerate; 
ATP, adenosine triphosphate; AK, adenylate kinase; and AMP, 
adenosine monophosphate. 
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Fig. 2. Phosphoglycerate kinase (PGK} and 
adenylate kinase (AK) banding patterns. 
Samples are as follows: Slot 1, extract of a 
single fruit fly; Slot 2, rat blood hemolysate; 
Slot 3, Rhesus monkey blood hemolysate; 
Slot 4, mouse blood hemolysate; Slot 5, rab- 
bit blood hemolysate; and Slot 6, human 
blood hemolysate. All the hemolysates are 
diluted with 2 parts water. Areas of true PGK 
activity are those which do not also show AK 
activity. The PGK face was photographed 
after about 15 rain of development time while 
the AK was allowed to develop for about 45 
rain before photographing. Mouse A K migrates 
anodally and goes off the gel in the 8 h period. 
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us ing  t he  a p p r o p r i a t e  e n z y m e  subs t ra tes .  F igure  1 should  
be c o n s u l t e d  to  c lar i fy  t h e  overa l l  s teps  in t he  s t a in ing  
procedure .  
I n  t he  fol lowing descr ip t ion,  all concen t r a t i ons  are 
expressed  in t e r m s  of t he  f ina l  c o n c e n t r a t i o n  in t he  
over lay.  
The  1, 3 -DPG gene ra t i ng  sys t em consis ts  of 0 .00219M 
g lyce r a ldehyde -3 -phos pha t e  (GAP), 0 .00033M nico t in-  
amide  aden ine  d inuc leo t ide  (NAD), 0 . 0 1 M  K2HPO4, 
0 . 0 6 M  p y r u v a t e ,  6.1 un i t s  l ac t a t e  dehyd rogenase  
(LDIff) pe r  ml,  and  2.1 un i t s  G A P D  per  ml.  These  compo-  
n e n t s  are d i s s o l v e d  in a t h i r d  of t he  Tris-HC1, 0 . I M  
p H  7 buffer  to  be  used a n d  th i s  is i n c u b a t e d  a t  37 ~ for 
30 rain.  P y r u v a t e  and  L D H  are  used to  keep t he  levels 
of r educed  N A D  (NADH)  low since h i g h  levels can  pro-  
duce too  d a r k  of a b a c k g r o u n d  in t he  over lay.  
To t he  1 , 3 - D P G  gene ra t i ng  sys tem,  a f t e r  30 m i n  
i ncuba t ion ,  are added  t he  r eagen t s  of t h e  A T P  de tec t ion  
sys tem,  wh ich  are 0 .0011M ADP,  0 . 0 1 M  glucose, 0 . 1 1 M  
MgCI~, 0 .00043M nico t ine  aden ine  d inuc l eo t idephospha t e ,  
0 .00039M p h e n a z i n e  me thosu l fa t e ,  0 .00029M MTT, 
0.5 m g  G 6 P D  per  ml,  and  0.1 m g  H K  per  ml. T he  r e s u l t a n t  
so lu t ion  is mixed  w i t h  a m o l t e n  (40 ~ Ion -aga r  so lu t ion  
m a d e  f rom the  r e m a i n i n g  2/3 buffer  to  give a f ina l  aga r  
c o n c e n t r a t i o n  of 0.75%. T he  f inal  agar  so lu t ion  is t h e n  
poured  over  t he  surface of t he  s t a r ch  gel and  i n c u b a t e d  
a t  37 ~ 
B a n d s  of P G K  ac t i v i t y  will  a p p e a r  well  w i t h i n  30 rain  
and  should  be  p h o t o g r a p h e d  or scored. Because  of t he  
presence  of c o m p o n e n t s  of t he  1, 3 -DPG gene ra t ing  sys tem,  
t he  over l ay  will d a r k e n  w i t h  more  t i m e  and  b a n d s  will 
be d i f f icul t  to  see. 
Some of t he  b a n d s  seen m a y  be  due to a d e n y l a t e  k inase  
(AK) a c t i v i t y  and  n o t  P G K .  Since A K  can  conve r t  
A D P  to A T P  w i t h o u t  t he  need for a n y  o the r  cosubs t ra tes ,  
s t a in ing  t he  o the r  face of t he  gel w i th  a n  over lay  s imi la r  
to t he  above  b u t  m i n u s  t he  1, 3 -DPG gene ra t i ng  sys t em 
will i nd ica te  wh ich  are A K  bands .  A K  b a n d s  usua l ly  t ake  
m u c h  longer  to  deve lop  t h a n  P G K  bands .  
S t a r c h  gels were r u n  for 8 h us ing  t he  p H  7 h i s t id ine  
gel a n d  c i t r a t e  br idge  buf fe r  s y s t e m  a n d  e lec t rophore t i c  
se tup  descr ibed  b y  BREWER 6 for p y r u v a t e  kinase.  
Results and discussion. In  F igure  2 can  be seen t he  
s t a r c h  gel P G K  b a n d i n g  p a t t e r n  of se lected samples .  The  
specif ic i ty  of t h e  s t a in  is a t t e s t e d  to b y  t he  fac t  t h a t  t he  
P G K  b a n d s  do no t  a p p e a r  if e i the r  G A P  or G A P D  are 
o m i t t e d  f rom the  1 ,3-DPG gene ra t i ng  sys tem.  F u r t h e r ,  a 
commerc ia l  P G K  p r e p a r a t i o n  (yeast) was  found  to 
p roduce  a b a n d  only  w i t h  t he  comple te  s tain.  Sepa ra t e  
s t a in ing  for L D H  also r e m o v e d  t he  r e m o t e  poss ib i l i ty  
t h a t  these  b a n d s  could r ep resen t  th i s  ac t iv i ty .  
The  p rev ious  s y s t e m  for de t ec t ing  P G K  a c t i v i t y  ut i l izes 
t he  reverse  r eac t ion  of P G K .  I n  th i s  s y s t e m  1, 3 -DPG is 
fo rmed  a t  t he  si te  of e n z y m e  a c t i v i t y  on  gels a n d  is 
de t ec t ed  b y  a G A P D / N A D H  sys tem.  The  areas  of a c t i v i t y  
can  be  v isua l ized  u n d e r  UV- l igh t  as less f luorescen t  areas  
(NAD) aga ins t  a f luorescen t  b a c k g r o u n d  (NADH)  5. 
The  commerc ia l  a v a i l a b i l i t y  of 1 , 3 - D P G  would,  of 
course, g rea t ly  s impl i fy  t he  pos i t ive  s t a in ing  t e c h n i q u e  
descr ibed  ill t h i s  c o m m u n i c a t i o n  and  add  to i ts  a t t r ac -  
t iveness .  Never the less ,  our  exper ience  w i t h  t he  pos i t ive  
s t a in  ha s  been  more  sa t i s fy ing  t h a n  t h a t  w i t h  t he  fluores- 
cen t  t echn ique .  I n  fact ,  our  diff icul t ies  in v i sua l iz ing  ban -  
d ing  p a t t e r n s  u n d e r  UV- l igh t  (as r equ i red  w i th  t he  fluo- 
r e scen t  t echn ique)  were t he  i m p e t u s  for  deve lop ing  t h e  
pos i t ive  s tain.  
I n  a s t u d y  p re sen t l y  in progress  invo lv ing  over  15 
species (both  p l a n t  and  an imal )  we h a v e  h a d  no t roub le  
o b t a i n i n g  P G K  b a n d s  w i t h  t he  pos i t ive  t e c h n i q u e  and  
d i s t ingu i sh ing  t h e m  f rom A K  bands .  Thus ,  the  t e c h n i q u e  
mos t  l ikely ha s  wide species appl icab i l i ty .  
Zusammenfassung. Eine  Methode  zur  pos i t i ven  Anf/ir-  
b u n g  der  P h o s p h o g l y c e r a t - K i n a s e  (EC 2.7.2.3) n a c h  St/ir- 
kege le lek t rophorese  wird  beschr ieben.  Das  in de r  Vor-  
w~tr tsreakt ion des E n z y m s  gebi lde te  Adenos in -Tr iphos -  
p h a t  wi rd  m i t  e inem I n d i k a t o r s y s t e m  (Hexokinase ,  
G lukose -6 -phospha t -Dehydrogenase ,  Te t razol iumsalz)  er- 
fasst.  
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An A p p a r a t u s  Sui table  for Ser ia l  D e t e r m i n a t i o n s  of F ibr ino ly t i c  Ac t iv i ty  
Var ious  m e t h o d s  h a v e  a l r eady  been  descr ibed  for de ter -  
m i n i n g  t he  inf luence  of d rugs  on  the  f ib r ino ly t i c  a c t i v i t y  
of p l a s m a  in v i t ro  I-9,11,13 or in  v ivo  in p r e t r e a t e d  ani-  
mals  12. Since t he  n u m b e r  of samples  to  be t e s t ed  m a y  be  
ve ry  large, t he  cons t r uc t i on  of a t i m e - s av i ng  device to 
fac i l i ta te  t he  e s t i m a t i o n  of f ib r ino ly t i c  a c t i v i t y  appea r s  
well  w o r t h  t he  effort .  Such  a n  a p p a r a t u s  is p a r t i c u l a r l y  
useful  when,  i n s t ead  of a s t r a i g h t - f o r w a r d  m e a s u r e m e n t  
of lysis t ime,  t he  clots  h a v e  to  be  t r e a t e d  in  a ce r t a in  way  
or a sample  of t he  i n c u b a t i o n  m e d i u m  t a k e n  in order  to  
define t he  mode  of action of a p r e p a r a t i o n  1,12. 
W e  h a v e  the re fore  des igned a n  a p p a r a t u s  p e r m i t t i n g  
the  lysis of 20 clots  to  be  s tud ied  in va r ious  respects .  One 
po in t  to  wh ich  we a t t a c h e d  p a r t i c u l a r  i m p o r t a n c e  was 
t h a t  t he  f o r m a t i o n  a n d  t r e a t m e n t  (e.g. r ins ing)  of t he  
clots,  as well  as t he  r e m o v a l  of samples  of the  i n c u b a t i o n  
med ium,  could be effected s i m p l y  and  as nea r ly  as possible  
s i m u l t a n e o u s l y  in al l  specimens.  
The  a p p a r a t u s  consis ts  essent ia l ly  of the  fol lowing 
p a r t s  (Figure  1): r e c t a n g u l a r  c ab i ne t  box  (A); a s u p p o r t  
p l a t e  (B) ; exchangeab le  clot  rods  (C) a n d  racks  for t e s t  
t u b e s  (D) of d i f fe ren t  sizes. 
Cabinet. The  c a b i n e t  is a r igid box,  on  t he  base  (a) of 
which  special  t e s t - t u b e  racks  are p laced  (D). A ve r t i ca l  
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